The definition and meaning of treatment-resistant depression.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 11480879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

  2000cited by this paper
• A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.

  2000cited by this paper
• The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.

  2000cited by this paper
• Treatment resistant depression: methodological overview and operational criteria.

  1999cited by this paper
• Lamotrigine in the treatment of bipolar depression.

  1999cited by this paper
• The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.

  1999cited by this paper
• Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression

  1999cited by this paper
• Course of treatment received by depressed patients.

  1999cited by this paper
• Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.

  1999cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1998cited by this paper
• Declaration of treatment failures.

  1997cited by this paper
• The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression.

  1997cited by this paper
• Low use of neuroleptic drugs in the treatment of psychotic major depression.

  1997cited by this paper
• [Pharmacological treatment of delusional depression].

  1996cited by this paper
• Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?

  1996cited by this paper
• Resistance to antidepressant medications and short-term clinical response to ECT.

  1996cited by this paper
• Management options for refractory depression.

  1996cited by this paper
• Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression

  1995cited by this paper
• Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine

  1994cited by this paper
• Psychotic (delusional) depression: a meta-analysis of physical treatments.

  1992cited by this paper
• The Practice of ECT: Recommendations for Treatment, Training and Privileging.

  1990cited by this paper
• The Impact of Medication Resistance and Continuation Pharmacotherapy on Relapse following Response to Electroconvulsive Therapy in Major Depression

  1990cited by this paper
• Medication resistance and clinical response to electroconvulsive therapy.

  1990cited by this paper
• Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.

  1989cited by this paper
• Antidepressant specificity in atypical depression.

  1988cited by this paper
• Continuation drug therapy for major depressive episodes: how long should it be maintained?

  1986cited by this paper
• Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients.

  1986cited by this paper
• Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.

  1986cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• Duration of antidepressant drug treatment. What is an adequate trial?

  1984cited by this paper
• The treatment of affective disorders in the elderly.

  1983cited by this paper
• Treatment received by depressed patients.

  1982cited by this paper
• On the role of plasma level monitoring of tricyclic antidepressants in clinical practice.

  1978cited by this paper
• Plasma nortriptyline levels—relationship to clinical effects

  1974cited by this paper
• MANIC DEPRESSIVE ILLNESS

  1970cited by this paper

• Postictal agitation is associated with brain-wide postictal microstructural changes after electroconvulsive therapy-induced seizures.

  2026cites this paper
• Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an EEG study providing insight into mechanism of action and a potentially predictive biomarker of efficacy

  2026cites this paper
• Biotypes of deeply phenotyped depressed patients reflect signatures of adverse childhood experience and depressive cognitive biases

  2025cites this paper
• Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review

  2025cites this paper
• Sex differences in the network structures of depressive symptom profiles in Asian patients with depressive disorders: findings from the Research on Asian Psychotropic Patterns for Antidepressants, Phase 3

  2025cites this paper
• Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.

  2025cites this paper
• Iyengar yoga and health education interventions for prolonged grief disorder in later life: feasibility of a randomized controlled pilot trial

  2025cites this paper
• Effects of Personality Styles on Clinical Response to Intermittent Theta Burst Stimulation for Depression

  2025cites this paper
• Ketamine's Influence on Magnetoencephalography Patterns During a Working Memory Task in Treatment‐Resistant Depression: An Exploratory Study

  2025cites this paper
• Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study.

  2025cites this paper
• Assessment of complement cascade components in patients with major depressive disorder.

  2025cites this paper
• Transcriptional profiling of antidepressant ketamine and electroconvulsive therapy treatment

  2025cites this paper
• The Effects of Psychotherapy on Single and Repeated Ketamine Infusion(s) Therapy for Treatment-Resistant Depression: The Convergence of Molecular and Psychological Treatment

  2025cites this paper
• Left prefrontal intermittent theta-burst stimulation therapy for major depressive disorder: A real-world, multisite observational study in Japan.

  2025cites this paper
• Improving adherence to physical activity in treatment-resistant depression: Protocol for a pilot randomized controlled trial of a remotely delivered program

  2025cites this paper
• Abnormally slow dynamics in occipital cortex of depression.

  2025cites this paper
• Association of sleep disruption with treatment response using intermittent theta-burst stimulation for treatment-resistant depression

  2025cites this paper
• Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depression.

  2025cites this paper
• Effect of ketamine and esketamine on RNA expression and its relevance for depression: a systematic review.

  2025cites this paper
• Impaired experience-based attentional suppression in major depression: a neurophysiological and cognitive vulnerability marker

  2025cites this paper
• Glucosinolate Metabolites and Brain Health: An Updated Review on Their Potential Benefits in Neurodegenerative, Neurodevelopmental, and Psychiatric Disorders

  2025cites this paper
• Spontaneous neural activity mediates the effect of adverse childhood experiences on negative cognitive styles in mood disorders: a multivariate approach.

  2025cites this paper
• Psychological and neurophysiological measures of emotion dysregulation in borderline personality disorder and posttraumatic stress disorder

  2025cites this paper
• Cognitive function in physically healthy, unmedicated individuals with major depression: Relationship with depressive symptoms and antidepressant response.

  2025cites this paper
• Trajectories of Response to Bilateral rTMS in Late-life Depression.

  2025cites this paper
• Decreased long-interval intracortical inhibition in the dorsolateral prefrontal cortex using TMS-EEG in patients with treatment-resistant depression.

  2025cites this paper
• Functional connectivity differences in patients with mood disorders: an exploratory fMRI study comparing electroconvulsive therapy with pharmacological treatment

  2025cites this paper
• The habenula in mood disorders: A systematic review of human studies

  2025cites this paper
• Differential impact of manic versus depressive episode recurrence on longitudinal gray matter volume changes in bipolar disorder

  2025cites this paper
• Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorder.

  2025cites this paper
• Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder

  2025cites this paper
• Five-factor personality and antidepressant response to intermittent theta burst stimulation for major depressive disorder

  2025cites this paper
• Spatiotemporal dynamics of amygdala during implicit and explicit facial emotional recognition in major depressive disorder: An MEG study

  2025cites this paper
• Alterations of structural-functional coupling in bipolar disorder patients with suicidal ideation correlated with chronotype.

  2025cites this paper
• Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI study.

  2025cites this paper
• Associations between polygenic risk for anhedonia and functional brain activity during reward processing.

  2025cites this paper
• Affective bias predicts changes in depression during deep brain stimulation therapy

  2025cites this paper
• US FDA Approves Home-Delivered tDCS for Treating Depression.

  2025cites this paper
• Self-criticism predicts antidepressant effects of intermittent theta-burst stimulation in Major Depressive Disorder.

  2024cites this paper
• Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance.

  2024cites this paper
• A qualitative investigation of the Montgomery–Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression

  2024cites this paper
• Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder

  2024cites this paper
• Brain-based graph-theoretical predictive modeling to map the trajectory of anhedonia, impulsivity, and hypomania from the human functional connectome

  2024cites this paper
• Long-term follow-up of participants in ketamine clinical trials for mood disorders.

  2024cites this paper
• Antidepressant Exposure and DNA Methylation: Insights from a Methylome-Wide Association Study

  2024cites this paper
• Trajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression

  2024cites this paper
• Deep brain stimulation for refractory major depressive disorder: a comprehensive review

  2024cites this paper
• Entactogen Effects of Ketamine: A Reverse-Translational Study.

  2024cites this paper
• A Multisite, 6-Month, Open-Label Study of Maintenance Transcranial Magnetic Stimulation for Adolescents with Treatment-Resistant Depression

  2024cites this paper
• Long-Term Effects of Single and Repeated Ketamine Infusions on Treatment-Resistant Depression: A Retrospective Chart Review Study

  2024cites this paper
• Decreased prefrontal glutamatergic function is associated with a reduced astrocyte-related gene expression in treatment-resistant depression

  2024cites this paper
• Predictors of remission after repetitive transcranial magnetic stimulation for the treatment of late-life depression.

  2024cites this paper
• Structural Brain Connectivity and Treatment Improvement in Mood Disorder

  2024cites this paper
• Auditory P50 Sensory Gating Alterations in Major Depressive Disorder and their Relationship to Clinical Symptoms.

  2024cites this paper
• Terapijski rezistentna depresija: nove spoznaje u etiopatogenezi i uloga esketamina u liječenju

  2024cites this paper
• Benefits and Risks of Esketamine Nasal Spray Continuation in Treatment-Resistant Depression

  2024cites this paper
• Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).

  2024cites this paper
• Associations Between Neighborhood Resources and Youth's Response to Reward Omission in a Task Modeling Negatively Biased Environments.

  2024cites this paper
• Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical Trial.

  2024cites this paper
• GluN2B on Adult-Born Granule Cells Modulates (R,S)-Ketamine’s Rapid-Acting Effects in Mice

  2024cites this paper
• Neuroplasticity of the left dorsolateral prefrontal cortex in patients with treatment-resistant depression as indexed with paired associative stimulation: a TMS–EEG study

  2024cites this paper
• Abnormal global signal topography of self modulates emotion dysregulation in major depressive disorder

  2023cites this paper
• Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression

  2023cites this paper
• Approach to Diagnosis and Management of Treatment-Resistant Depression.

  2023cites this paper
• Photobiomodulation: An Emerging Treatment Modality for Depression.

  2023cites this paper
• A Systematic Review Assessing Patient-Related Predictors of Response to Transcranial Magnetic Stimulation in Major Depressive Disorder

  2023cites this paper
• Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression

  2023cites this paper
• Special Populations: Treatment-Resistant Depression in Children and Adolescents.

  2023cites this paper
• Apparent Lack of Benefit of Combining Repetitive Transcranial Magnetic Stimulation with Internet-Delivered Cognitive Behavior Therapy for the Treatment of Resistant Depression: Patient-Centered Randomized Controlled Pilot Trial

  2023cites this paper
• κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine

  2023cites this paper
• Study to determine the epidemiology of treatment-resistant depression among the Saudi Arabian population: A cross-sectional study

  2023cites this paper
• Majör Depresyon Bozukluğunun Bilişsel Davranışçı Terapi Yaklaşımı ile Tedavisi: Olgu Sunumu

  2023cites this paper
• Comparison of coil placement approaches targeting dorsolateral prefrontal cortex in depressed adolescents receiving repetitive transcranial magnetic stimulation: an electric field modeling study

  2023cites this paper
• Your smile won’t affect me: Association between childhood maternal antipathy and adult neural reward function in a transdiagnostic sample

  2023cites this paper
• Local Injection for Treating Mood Disorders (LIFT-MOOD): A Pilot Feasibility RCT of Stellate Ganglion Block for Treatment-Resistant Depression

  2023cites this paper
• A machine learning pipeline for efficient differentiation between bipolar and major depressive disorder based on multimodal structural neuroimaging

  2023cites this paper
• Whole brain network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression

  2023cites this paper
• Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study

  2023cites this paper
• Psychedelics for treatment resistant depression: are they game changers?

  2023cites this paper
• A naturalistic study comparing the efficacy of unilateral and bilateral sequential theta burst stimulation in treating major depression – the U-B-D study protocol

  2023cites this paper
• Brain-based graph-theoretical predictive modeling to map the trajectory of transdiagnostic symptoms of anhedonia, impulsivity, and hypomania from the human functional connectome

  2023cites this paper
• Dissociable salience and default mode network modulation in generalized anxiety disorder: a connectome-wide association study.

  2023cites this paper
• Challenges in defining treatment‐resistant mania in adults: A systematic review

  2023cites this paper
• Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

  2023cites this paper
• Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits

  2023cites this paper
• An exploration of actigraphy in the context of ketamine and treatment‐resistant depression

  2023cites this paper
• Multimodal structural neuroimaging data unveil data-driven subtypes of treatment-resistant depression.

  2023cites this paper
• Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD).

  2023cites this paper
• Brain‐derived subgroups of bipolar II depression associate with inflammation and choroid plexus morphology

  2023cites this paper
• Optimizing TMS Coil Placement Approaches for Targeting the Dorsolateral Prefrontal Cortex in Depressed Adolescents: An Electric Field Modeling Study

  2023cites this paper
• (R,S)-ketamine’s rapid-acting antidepressant effects are modulated by NR2B-containing NMDA receptors on adult-born hippocampal neurons

  2023cites this paper
• Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment

  2023influential citation
• Structural brain plasticity and inflammation are independently related to changes in depressive symptoms six months after an index ECT course.

  2023cites this paper
• Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life

  2023cites this paper
• The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.

  2023cites this paper
• Shared and distinct patterns of dynamic functional connectivity variability of thalamo-cortical circuit in bipolar depression and major depressive disorder.

  2023cites this paper
• Treatment-resistant depression in children and adolescents.

  2023cites this paper
• Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression

  2023cites this paper
• Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial

  2023cites this paper
• Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

  2023cites this paper